Slate Run Pharmaceuticals Eptifibatide Injection recalled for incorrect dosing instruction labeling

Check Slate Run Eptifibatide Injection labeling

Slate Run Pharmaceuticals is recalling Eptifibatide Injection 75 mg/100 mL vials because the carton label says "weight-adjusted bolus dosing" when it should say "weight-adjusted infusion." This labeling error could lead to incorrect administration of the medication. No injuries have been reported.

• If you are a healthcare provider or facility using this medication, verify the correct dosing method is weight-adjusted infusion, not bolus dosing.
• Contact Slate Run Pharmaceuticals or your pharmacy if you have questions about proper administration.
• Do not use this medication until you confirm the correct dosing instructions with your healthcare provider or pharmacist.